Crescendo Biologics
Subscribe
Submit Feedback
Claim
Crescendo Biologics
Claim
Biopharmaceutical company developing Humabody® therapeutics in oncology with a focus on innovative targeted T-cell approaches.
Biopharmaceutical company developing Humabody® therapeutics in oncology with a focus on innovative t
Show More
Alpha Score
70.7
Total Funding
$ 102.79 M
Alpha Score
70.7
Show Alpha Predictions
Predictions
Overview
Team
Financials
Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0